Bernard Kasten

SeraCare Life Sciences, Inc. provides in vitro diagnostics and clinical laboratory products. It supplies diagnostic quality controls, biological materials, and reagents to in vitro diagnostics developers, clinical laboratories, and life science researchers. The firm’s products include Next-Gen Sequencing and Digital PCR Tools, Controls and Reference Materials, Validation and Lot Qualification Materials, Plasma and Serum Diluents/Derivatives, Cell Culture Reagents, KPL Antibodies and Conjugates and KPL Immunoassay Reagents and Kits. The company was founded in 1984 and is headquartered in Milford, MA.

Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY.

MedPlus, Inc. developed and integrated healthcare technology solutions. The company offers clinical connectivity and healthcare information exchange solutions for physician practices, hospitals, integrated delivery networks, community regional health information networks, and health information exchanges. The company was founded in 1991 and was headquartered in Mason, OH.

The College of American Pathologists is the largest organization of board-certified pathologists in the world. The non-profit company is based in Northfield, IL. The company provides laboratory accreditation and proficiency testing programs to promote excellence in the practice of pathology and laboratory medicine globally. The House of Delegates represents the voice of CAP membership and is responsible for steering committee, delegate responsibilities, elections timeline, meetings, and more.

Lexi-Comp is an industry-leading provider of drug information and clinical content for the healthcare industry. They provide the tools necessary to help improve patient safety, ensure compliance, and elevate the quality of care patients receive. Lexi-Comp’s content and technology provide relevant, real-time information at the point-of-care in both in-patient and out-patient settings to help improve patient outcomes, workflow efficiency, and medication safety. Along with its leading drug database, Lexi-Drugs®, content areas include pediatric drug information, pharmacology, interactions, diagnostic procedures & laboratory tests, pharmacogenomics, poisoning & toxicology, dentistry, infectious diseases, and patient education. Over 500,000 clinicians worldwide access Lexi-Comp’s information via the Internet, handheld devices, and through integration with health information systems. An extensive library of print titles is also available.